1. Home
  2. EXAS vs CF Comparison

EXAS vs CF Comparison

Compare EXAS & CF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • CF
  • Stock Information
  • Founded
  • EXAS 1995
  • CF 1946
  • Country
  • EXAS United States
  • CF United States
  • Employees
  • EXAS N/A
  • CF N/A
  • Industry
  • EXAS Medical Specialities
  • CF Agricultural Chemicals
  • Sector
  • EXAS Health Care
  • CF Industrials
  • Exchange
  • EXAS Nasdaq
  • CF Nasdaq
  • Market Cap
  • EXAS 12.3B
  • CF 14.3B
  • IPO Year
  • EXAS N/A
  • CF 2005
  • Fundamental
  • Price
  • EXAS $49.33
  • CF $87.03
  • Analyst Decision
  • EXAS Strong Buy
  • CF Hold
  • Analyst Count
  • EXAS 17
  • CF 12
  • Target Price
  • EXAS $73.07
  • CF $87.45
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • CF 1.8M
  • Earning Date
  • EXAS 11-05-2024
  • CF 10-30-2024
  • Dividend Yield
  • EXAS N/A
  • CF 2.30%
  • EPS Growth
  • EXAS N/A
  • CF N/A
  • EPS
  • EXAS N/A
  • CF 6.29
  • Revenue
  • EXAS $2,692,328,000.00
  • CF $5,983,000,000.00
  • Revenue This Year
  • EXAS $12.41
  • CF N/A
  • Revenue Next Year
  • EXAS $11.64
  • CF $1.38
  • P/E Ratio
  • EXAS N/A
  • CF $13.84
  • Revenue Growth
  • EXAS 11.91
  • CF N/A
  • 52 Week Low
  • EXAS $40.62
  • CF $69.13
  • 52 Week High
  • EXAS $79.62
  • CF $90.86
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 22.62
  • CF 58.74
  • Support Level
  • EXAS $48.02
  • CF $82.47
  • Resistance Level
  • EXAS $52.32
  • CF $87.77
  • Average True Range (ATR)
  • EXAS 2.86
  • CF 2.24
  • MACD
  • EXAS -1.89
  • CF 0.27
  • Stochastic Oscillator
  • EXAS 5.28
  • CF 72.55

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About CF CF Industries Holdings Inc.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally. The company is also investing in carbon-free blue and green ammonia, which can be used an alternative fuel to hydrogen or as a means to transport hydrogen.

Share on Social Networks: